Trial Profile
Clinical Trials Insight: 700014262
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jul 2019
Price :
$35
*
At a glance
- Drugs Hydromorphone (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Cassava Sciences; King Pharmaceuticals; Pain Therapeutics
- 12 Dec 2006 Status change
- 07 Aug 2006 New trial record.